BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 1656248)

  • 1. [Epstein-Barr-virus-induced lymphoproliferative diseases].
    Schuster V; Kreth HW
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
    Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between Epstein-Barr virus and lymphoma.
    Bird AG; Britton S
    Semin Hematol; 1982 Oct; 19(4):285-300. PubMed ID: 6297094
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epstein-Barr virus infection--a lympho- and epitheliotropic infection].
    Näher H; Petzoldt D
    Hautarzt; 1992 Mar; 43(3):114-9. PubMed ID: 1315723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus and the X-linked lymphoproliferative syndrome.
    Sullivan JL
    Adv Pediatr; 1983; 30():365-99. PubMed ID: 6324556
    [No Abstract]   [Full Text] [Related]  

  • 6. Epstein-Barr virus-associated lymphoproliferative disorders.
    Purtilo DT; Strobach RS; Okano M; Davis JR
    Lab Invest; 1992 Jul; 67(1):5-23. PubMed ID: 1320711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunodeficiency as a factor in lymphomagenesis.
    Purtilo DT; Sakamoto K
    Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent aspects of Epstein-Barr virus infections].
    Hasler F
    Schweiz Med Wochenschr; 1984 Apr; 114(15):520-3. PubMed ID: 6328644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biology of the Epstein-Barr virus].
    Morand P; Seigneurin JM
    Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.
    Purtilo DT; Sakamoto K; Saemundsen AK; Sullivan JL; Synnerholm AC; Anvret M; Pritchard J; Sloper C; Sieff C; Pincott J; Pachman L; Rich K; Cruzi F; Cornet JA; Collins R; Barnes N; Knight J; Sandstedt B; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4226-36. PubMed ID: 6272967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of EBV hybridization in clinical and biological medicine.
    Morinet F
    Nouv Rev Fr Hematol (1978); 1989; 31(2):155-8. PubMed ID: 2549502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G; Purtilo D
    Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract]   [Full Text] [Related]  

  • 14. The spectrum of Epstein-Barr virus disease.
    O'Dell JR
    Nebr Med J; 1981 Dec; 66(12):275-8. PubMed ID: 6283398
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U; Weiss M; Belohradsky BH
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.
    Borisch-Chappuis B; Nezelof C; Müller H; Müller-Hermelink HK
    Am J Pathol; 1990 Apr; 136(4):751-8. PubMed ID: 1691592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency.
    Reece ER; Gartner JG; Seemayer TA; Joncas JH; Pagano JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4243-7. PubMed ID: 6272969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing faces of EBV research.
    Klein G; Klein E
    Prog Med Virol; 1984; 30():87-106. PubMed ID: 6087416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.